Dysplasia and carcinoma development in a repeated dextran sulfate sodium-induced colitis model

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue 10, 2002, Pages 1078-1083

  Okayasu, Isao ^a   Yamada, Masahiro ^b   Mikami, Tetuo ^a   Yoshida, Tsutomu ^a   Kanno, Jun ^c   Ohkusa, Toshifumi ^d  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Yamada Clinic   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^d JUNTENDO UNIVERSITY   (Japan)

Author keywords

Bromodeoxyuridine; Dextran sulfate sodium; Dysplasia; Mouse model; Ulcerative colitis

Indexed keywords

BROXURIDINE; DEXTRAN SULFATE; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRADING; CANCER INVASION; CARCINOGENESIS; COLITIS; COLORECTAL TUMOR; CONTROLLED STUDY; DISTILLATION; DYSPLASIA; FEMALE; IN VIVO STUDY; MOLECULAR WEIGHT; MOUSE; MUCOSA; NONHUMAN; PRIORITY JOURNAL; TIME; ULCERATIVE COLITIS;

EID: 0036051423     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2002.02853.x     Document Type: Article

References (29)

1. Risk of malignant change in ulcerative colitis
2. Dysplasia and malignancy in inflammatory bowel disease
3. Precancer and cancer in extensive ulcerative colitis: Findings among 401 patients over 22 years
4. Development of colorectal cancer in ulcerative colitis. Clinicopathological study of 347 patients and new concepts of cancer development from analysis of mucosal cell proliferation activity
5. Enhanced epithelial cell turnover associated with p53 accumulation and high p21WAF1/CIP1 expression in ulcerative colitis
6. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice
7. Promotion of colorectal neoplasia in experimental murine ulcerative colitis
8. Degraded carrageenan-induced colitis in DF1 mice. A clinical, histopathological and kinetic analysis
9. Dysplasia in inflammatory bowel disease: Standard classification with provisional clinical applications
10. The role of bacteria in experimental ulcerative colitis
11. A comparison of three immunoperoxidase techniques for antigen detection in colorectal carcinoma tissues
12. The correlation of experimental carcinogenesis and cancer in man
13. Present trends in cancer epidemiology
14. Pathology of intestinal neoplasms and other lesions in rats exposed to azoxymethane
15. Investigation into the metabolism and mode of action of the colon carcinogen 1,2-dimethylhydrazine
16. The significant prognosis of direct extension of carcinoma of the colon and rectum
17. Mutagenicity and cytogenicity studies of dextran sulfate
18. Experimental models of inflammatory bowel disease
19. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice
20. Rate and pattern of epithelial proliferation in ulcerative colitis
21. Significant increase in prostaglandin E-main urinary metabolite by laxative administration: Comparison with ulcerative colitis
22. Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo
23. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease
24. Distribution of inducible nitric oxide synthase in ulcerative colitis
25. Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease
26. Resistance to apoptosis and cyclooxygenase-2 expression in a human adenocarcinoma cell line HT29 CL. 19A
27. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression
28. Nitric oxide inhibits Fas-induced apoptosis